LAM PHARMICEUTICAL CORP
10SB12G/A, EX-27, 2000-07-19
PHARMACEUTICAL PREPARATIONS
Previous: LAM PHARMICEUTICAL CORP, 10SB12G/A, 2000-07-19
Next: LAM PHARMICEUTICAL CORP, 10SB12G/A, EX-27, 2000-07-19



<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001071272
<NAME>                        L.A.M. Pharmaceutical, Corp.
<MULTIPLIER>                                   1
<CURRENCY>                                     US

<S>                             <C>
<PERIOD-TYPE>                                  12-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-1-1999
<PERIOD-END>                                   DEC-31-1999
<EXCHANGE-RATE>                                1
<CASH>                                         1,023,710
<SECURITIES>                                   0
<RECEIVABLES>                                  125,000
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               1,148,710
<PP&E>                                         39,106
<DEPRECIATION>                                 34,184
<TOTAL-ASSETS>                                 1,386,049
<CURRENT-LIABILITIES>                          1,363,627
<BONDS>                                        1,252,000
                          0
                                    0
<COMMON>                                       1,039
<OTHER-SE>                                     (1,576,814)
<TOTAL-LIABILITY-AND-EQUITY>                   1,386,049
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  2,398,000
<OTHER-EXPENSES>                               82,659
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (2,480,983)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (2,480,983)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,480,983)
<EPS-BASIC>                                    (0.24)
<EPS-DILUTED>                                  (0.24)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission